IMMUNOSCORE IC
Live / Registered — Registered (as of 05 Mar 2024)
What this means for you
Registered since 05 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79342738
- Registration number
- 7318047
- Mark type
- Stylized text
- Filed
- 29 Apr 2022
- Published for opposition
- 19 Dec 2023
- Registered
- 05 Mar 2024
- Attorney of record
- Rosaleen H. Chou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, pharmaceutical products for use in the treatment of cancer; chemical preparations for medical and pharmaceutical use, namely for use in the treatment of cancer; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for providing information on diagnostics or identification of biological systems for medical use; immunological reagents for medical use; biological reagents for medical diagnosis; diagnostic kits comprising medical diagnostic reagents and medical diagnostic tests for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis
- Class 009 — Scientific and electric apparatus: Downloadable or recorded software for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors; downloadable application software in the field of clinical biology for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors
- Class 042 — Scientific and technological services: Research, development, technical design and scientific testing services, namely scientific research for relating to cancer treatment; industrial analysis and research services in the fields of immuno-oncology and cancer research; clinical trial services, namely providing laboratory testing in clinical trials; tests in laboratories, namely in the fields of immuno-oncology and cancer research; development of testing methods for others in the fields of immuno-oncology and cancer research; research, development, technical design, testing, consultancy and analysis services in the field of immuno-oncology; research services in the field of genome and immune index analysis; design and development of software in the field of biology
- Class 044 — Medical, beauty and agricultural services: Medical analysis services for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; medical assistance; medical diagnostics and diagnostics in the field of medicine, namely in the fields of immuno-oncology and cancer research; genetic analysis services, namely in the fields of immuno-oncology and cancer research
Owner
Prosecution history
- 14 Aug 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2023 — NOTIFICATION PROCESSED BY IB
- 19 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Dec 2023 — PUBLISHED FOR OPPOSITION
- 11 Dec 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 29 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Nov 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 29 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 22 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 09 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER